Recombinant adenoviral vector and method of use

Details Recombinant adenoviral vector and method of use Recombinant adenoviral vector and method of use

2006-05-09

2006-05-09

Guzo, David (Department: 1636)

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

Genetically modified micro-organism, cell, or virus

C424S093100, C424S093600, C435S320100, C435S069100, C435S455000, C435S456000, C435S325000

Reexamination Certificate

active

07041284

ABSTRACT:
This invention provides a recombinant adenovirus expression vector characterized by the partial or total deletion of the adenoviral protein IX DNA and having a gene encoding a foreign protein or a functional fragment or mutant thereof. Transformed host cells and a method of producing recombinant proteins and gene therapy also are included within the scope of this invention. Thus, for example, the adenoviral vector of this invention can contain a foreign gene for the expression of a protein effective in regulating the cell cycle, such as p53, Rb, or mitosin, or in inducing cell death, such as the conditional suicide gene thymidine dinase. (The latter must be used in conjunction with a thymidine kinase metabolite in order to be effective.)

REFERENCES:
patent: 6290949 (2001-09-01), French et al.
patent: 6333030 (2001-12-01), Curiel
patent: 6503501 (2003-01-01), Anderson et al.
patent: 6613563 (2003-09-01), Sosnowski et al.
patent: 2003/0091534 (2003-05-01), Gregory et al.
Buller et al., Cancer Gene Therapy, vol. 9, 2002, pp. 553-566.
Kuball et al., Journal of Clinical Oncology, vol. 20, No. 4, 2002, pp. 957-965.
Marshall, Science, vol. 299, 2003, p. 320.
Fox, Nature Biotechnology, vol. 18, 2000, pp. 143-144.
Gomez-Navarro et al., European Journal of Cancer, vol. 35, No. 6, 1999, pp. 867-885.
Wen et al., Cancer Gene Therapy, vol. 10, 2003, pp. 224-238.
W. French Anderson, Nature, vol. 392, pp. 25-30, Apr. 30, 1998.
Gura, Science, vol. 278, pp. 1041-1042, Nov. 7, 1997.
Twersky, “Girl's Parents Plead for Gene Therapy to Resume,” WebMD Health, Sep. 27, 2000.
Weiss et al., “Methods Faulted in Fatal Gene Therapy,” Washington Post, Dec. 8, 1999, p. A1.
“Gene Therapy Shows Promise for Fighting Cancer,” ACS News Center, Aug. 21, 2000.

Affiliated with

Also associated with

Rating

Recombinant adenoviral vector and method of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Recombinant adenoviral vector and method of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant adenoviral vector and method of use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3555877